Search for: "Discovery Benefits, Inc."
Results 861 - 880
of 1,957
Sorted by Relevance
|
Sort by Date
12 Sep 2011, 6:18 am
Shire pointed to paragraphs in the employment agreement that make all discoveries or inventions made by Mickle the property of the company; that prohibit Mickle from disclosing company confidential information for his own benefit; and that require that all patents and other intellectual property developed by Mickle be assigned to the company. [read post]
30 Sep 2010, 2:56 am
., clinical research director of Somalogic Inc. [read post]
9 May 2010, 5:22 pm
In Rent-A-Center West Inc. v. [read post]
27 Mar 2008, 1:55 pm
Mukasey CIVIL PROCEDURE, ERISA, GOVERNMENT BENEFITS, HEALTH LAW, INSURANCE LAW, LABOR & EMPLOYMENT LAW Krauss v. [read post]
3 Mar 2008, 6:29 am
Quite a fact pattern here: Constellation Brands, Inc. v. [read post]
26 Oct 2021, 6:53 am
Prometheus Labs., Inc., 132 S. [read post]
30 Oct 2021, 9:50 am
” CEDRIC SPRING & ASSOC., INC. v. [read post]
13 Apr 2014, 8:59 am
Discoveries. [read post]
21 Aug 2009, 2:30 pm
Nestle USA, Inc., the California Supreme Court issued guidance in determining when the statute of limitations runs on a claim for appropriation of likeness. [read post]
1 Dec 2015, 11:55 am
Justice Myers provided the following reasons: [32] With respect to the claim for LTD benefits, it is up to the plaintiff to show that she fell within the terms of the policy. [read post]
5 Nov 2010, 8:49 pm
Rudolph Technology Inc. began as a license dispute over semiconduictor technology that Rudolph Technology licensed for a few months but declined to purchase. [read post]
25 Mar 2011, 3:33 pm
EV3, Inc., et al. [read post]
20 May 2024, 6:26 am
Assen KoevThe resolution of many securities class action lawsuits would benefit from an economic assessment early in the case process. [read post]
24 Jan 2012, 12:05 pm
Arachnid, Inc. v. [read post]
2 Aug 2007, 2:58 am
Fiore Inc. [read post]
15 Mar 2010, 5:03 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
13 Jul 2007, 5:08 pm
., Inc. v. [read post]
14 May 2015, 7:28 am
If a treatment is so new that its risks and benefits cannot accurately be assessed, then a warning about its experimental nature is appropriate, but that kind of warning is a small subset of “off-label use” as an FDA regulatory status.Here is the article’s thesis:This Article proposes a fiduciary framework to regulate physician innovation under conditions of endogenous [we think that means “inherent” in this context] uncertainty. [read post]
5 Apr 2012, 2:33 pm
By Eric Goldman Viacom International, Inc., v. [read post]
14 Jul 2010, 6:47 pm
Stallergenes (EPLAW) UK: Discovery of documents: is there a real benefit? [read post]
